Acute kidney injury (AKI) is associated with death in critically ill patients, but this complication has not been well characterized after aneurysmal subarachnoid hemorrhage (aSAH). The purpose of this study was to determine the incidence of AKI after aSAH and to identify risk factors for renal dysfunction. Secondary objectives were to examine what effect AKI has on patient mortality and functional outcome at 12 weeks post-aSAH.
The authors performed a post hoc analysis of the Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1) trial data set (clinical trial registration no.: NCT00111085, https://clinicaltrials.gov). The primary outcome of interest was the development of AKI, which was defined according to the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines. Secondary outcomes of interest were death and a modified Rankin Scale score greater than 2 at 12 weeks post-aSAH. Propensity score matching was used to assess for a significant treatment effect related to clazosentan administration and AKI. Univariate analysis, locally weighted scatterplot smoothing (LOWESS) curves, and stepwise logistic regression models were used to evaluate for associations between baseline or disease-related characteristics and study outcomes.
One hundred fifty-six (38%) of the 413 patients enrolled in the CONSCIOUS-1 trial developed AKI during their ICU stay. A history of hypertension (p < 0.001) and the number of nephrotoxic medications administered (p = 0.029) were independent predictors of AKI on multivariate analysis. AKI was an independent predictor of death (p = 0.028) but not a poor functional outcome (p = 0.21) on multivariate testing. Unresolved renal dysfunction was the strongest independent predictor of death in this cohort (p < 0.001).
AKI is a common complication following aSAH. Patients with premorbid hypertension and those treated with nephrotoxic medications may be at greater risk for renal dysfunction. AKI appears to confer an increased probability of death after aSAH.
Correspondence Matthew E. Eagles: University of Calgary, AB, Canada. email@example.com.
INCLUDE WHEN CITING Published online July 12, 2019; DOI: 10.3171/2019.4.JNS19103.
Disclosures Dr. Macdonald reports ownership of Edge Therapeutics, Inc. and receiving non–study-related clinical or research effort support from the following organizations: Brain Aneurysm Foundation, Heart and Stroke Foundation of Canada, Canadian Institutes for Health Research, and Physicians Services Incorporated Foundation.
BellomoRRoncoCKellumJAMehtaRLPalevskyP: Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care8:R204–R2122004
BellomoR, RoncoC, KellumJA, MehtaRL, PalevskyP: Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. 8:R204–R212, 2004)| false
CharlsonME, PompeiP, AlesKL, MacKenzieCR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. 40:373–383, 1987355871610.1016/0021-9681(87)90171-8)| false
EaglesMETsoMKMacdonaldRL: Significance of fluctuations in serum sodium levels following aneurysmal subarachnoid hemorrhage: an exploratory analysis. J Neurosurg[epub ahead of print August 1 2018. DOI: 10.3171/2018.3.JNS173068]
EaglesME, TsoMK, MacdonaldRL: Significance of fluctuations in serum sodium levels following aneurysmal subarachnoid hemorrhage: an exploratory analysis. [epub ahead of print August 1, 2018. DOI: 10.3171/2018.3.JNS173068]30117765)| false
JamesMTGramsMEWoodwardMElleyCRGreenJAWheelerDC: A meta-analysis of the association of estimated GFR, albuminuria, diabetes mellitus, and hypertension with acute kidney injury. Am J Kidney Dis66:602–6122015
JamesMT, GramsME, WoodwardM, ElleyCR, GreenJA, WheelerDC, : A meta-analysis of the association of estimated GFR, albuminuria, diabetes mellitus, and hypertension with acute kidney injury. 66:602–612, 20152597596410.1053/j.ajkd.2015.02.338)| false
KassellNF, TornerJC, HaleyECJr, JaneJA, AdamsHP, KongableGL: The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. 73:18–36, 199010.3171/jns.1990.73.1.0018)| false
LeveyAS, BoschJP, LewisJB, GreeneT, RogersN, RothD: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. 130:461–470, 199910.7326/0003-4819-130-6-199903160-0000210075613)| false
PalevskyPM, LiuKD, BrophyPD, ChawlaLS, ParikhCR, ThakarCV, : KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. 61:649–672, 20132349904810.1053/j.ajkd.2013.02.349)| false
RayB, RickertKL, WelchBG, WhiteJA, KlingerDR, BoudreauxBP, : Development of contrast-induced nephropathy in subarachnoid hemorrhage: a single center perspective. 19:150–156, 201310.1007/s12028-013-9850-123653268)| false
SolenskiNJHaleyECJrKassellNFKongableGGermansonTTruskowskiL: Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study. Crit Care Med23:1007–10171995
SolenskiNJ, HaleyECJr, KassellNF, KongableG, GermansonT, TruskowskiL, : Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study. 23:1007–1017, 199510.1097/00003246-199506000-00004)| false
WartenbergKE, SchmidtJM, ClaassenJ, TemesRE, FronteraJA, OstapkovichN, : Impact of medical complications on outcome after subarachnoid hemorrhage. 34:617–624, 20061652125810.1097/01.CCM.0000201903.46435.35)| false
ZachariaBEDucruetAFHickmanZLGrobelnyBTFernandezLSchmidtJM: Renal dysfunction as an independent predictor of outcome after aneurysmal subarachnoid hemorrhage: a single-center cohort study. Stroke40:2375–23812009